Targeting PCNA/PARP1 axis inhibits the malignant progression of hepatocellular carcinoma - Li, Jipin; Yong, Tao; Chen, Yali; Zeng, Tingyu; Zhang, Kaifeng; Wang, Shuping; Zhang, Youcheng (Frontiers in Pharmacology, 2025)